Cited by 655Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisLiver physiology and pathologySystemic Sclerosis and Related Diseases

Therapy for Fibrotic Diseases: Nearing the Starting Line

Friedman, Scott L., Sheppard, Dean, Duffield, Jeremy S., Violette, Shelia·2013·Science Translational Medicine

Abstract

An emerging consensus indicates that fibrotic diseases in lung, liver, and kidney exhibit common underlying mechanisms, which can be targeted therapeutically.

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.3004700

Cites

209 of 209 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There is increasing appreciation of common pathways of fibrosis conserved among tissues, including TGFβ, CTGF, IL-4, IL-13, PDGF, and osteopontin.

    “Although tissue-specific features of fibrogenesis appear to exist, there is increasing appreciation of common pathways of fibrosis that are conserved among tissues, including transforming growth factor–β (TGFβ), connective tissue growth factor (CTGF), interleukin-4 (IL-4), IL-13, platelet-derived growth factor (PDGF), and osteopontin (19).”

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Friedman, S. L., Sheppard, D., Duffield, J. S., & Violette, S.
Affiliations
  • Icahn School of Medicine at Mount Sinai (US)
  • University of California, San Francisco (US)
  • University of Washington (US)
  • Biogen (United States) (US)
Corresponding author
Friedman, Scott L.
Venue
Science Translational Medicine
Published
2013-01-09
Volume
5
Issue
167
Pages
167sr1-167sr1
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2121339421
Cited by
655
References
209
Citations by year
2026: 17 · 2025: 29 · 2024: 38 · 2023: 38 · 2022: 55 · 2021: 48 · 2020: 64 · 2019: 55 · 2018: 50 · 2017: 52 · 2016: 50 · 2015: 62 · 2014: 62 · 2013: 30 · 2012: 3
FWCI
10.61
Type
journal article
Language
en
Open access
closed
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Alcohol Abuse and Alcoholism (R01AA020709, AA020709)
  • National Heart, Lung, and Blood Institute (P01HL108794, HL108794, HL53949, R01HL102292, HL102292)
  • National Institute of Allergy and Infectious Diseases (AI0774349)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK93493, DK94768, R01DK084077, R24DK094768, DK 56621, R01DK093493, DK84077)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Systemic Sclerosis and Related Diseases
Keywords
fibrosis, antifibrotic therapy, pulmonary fibrosis, renal fibrosis, liver cirrhosis, extracellular matrix, epithelial damage, fibrogenesis, biomarkers, drug development
MeSH terms
Extracellular Matrix, Fibrosis, Humans, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review